Search results for "Conti"

showing 10 items of 3486 documents

Posaconazole vs Standard Azole (FLU/ITRA) Therapy for Prophylaxis of Invasive Fungal Infections (IFIs) among High-Risk Neutropenic Patients: Results …

2005

Abstract Background: Patients with severe and prolonged neutropenia are at high-risk of developing life-threatening IFIs. Despite current treatment option, IFIs are difficult to treat and frequently associated with high mortality rates. Antifungal prophylaxis has shown benefits in high-risk populations and is a standard practice in many institutions. We compared Posaconazole (POS), a new broad-spectrum triazole, vs Standard Azoles for the prevention of IFIs in patients with a new diagnosis or first relapse of acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) being treated with intensive chemotherapy. Methods: Patients in this randomized, evaluator-blinded, active controlled…

medicine.medical_specialtyPosaconazoleItraconazolebusiness.industryImmunologyCell BiologyHematologyNeutropeniamedicine.diseaseBiochemistrySurgeryDiscontinuationTolerabilityInternal medicineMulticenter trialmedicineAdverse effectbusinessFluconazolemedicine.drugBlood
researchProduct

Continent urinary diversion in childhood

1992

Continence and a positive body image are important, especially to the adolescent patient. Since 1964 we have used ureterosigmoidostomy and have achieved a complete continence rate of 92.3%. The creation of a low-pressure reservoir by antimesenteric splitting of the recto-sigmoid eliminated many of the shortcomings of ureterosigmoidostomy. This procedure is termed the sigma-rectum pouch and has been applied in six children to date. Mainz-pouch bladder augmentation or substitution has been performed in 20 children, 17 of whom are completely continent. The results of the modified Young Dees procedure were disappointing. In three children, conversion into a continent diversion was necessary. Al…

medicine.medical_specialtyPositive body imageUrinary bladderbusiness.industryUrologymedicine.medical_treatmentUrinary diversionAdolescent patientSurgeryUreterosigmoidostomymedicine.anatomical_structureBladder augmentationmedicinePouchbusinessContinent Urinary DiversionWorld Journal of Urology
researchProduct

Non-invasive ventilation in postoperative patients: A systematic review

2010

Background: Postoperative pulmonary complications, generally defined as any pulmonary abnormality occurring in the postoperative period, are still a significant issue in clinical practice increasing hospital length of stay, morbidity and mortality. Non-invasive ventilation (NIV), primarily applied in cardiogenic pulmonary edema, decompensated COPD and hypoxemic pulmonary failure, is nowadays also used in perioperative settings. Objective: Investigate the application and results of preventive and therapeutic NIV in postsurgical patients. Design: A systematic review. Data sources: Medical literature databases were searched for articles about "clinical trials," "randomized controlled trials" a…

medicine.medical_specialtyPostoperative pneumoniamedicine.medical_treatmentIntensive Care UnitLung injuryAcute respiratory failureCritical Care and Intensive Care MedicinePositive-Pressure RespirationAnesthesiologyIntensive caremedicineHumansContinuous positive airway pressurePostoperative Carebusiness.industryPerioperativeCardiac surgerySurgeryIntensive Care UnitsCardiothoracic surgeryAnesthesiaNon-invasive ventilationAtelectasibusinessAbdominal surgeryHuman
researchProduct

Kontinente Harnableitung und Schwangerschaft

1995

We report on our experience with 7 pregnancies in 6 women who previously underwent reconstruction of the urinary tract with a continent urinary diversion using an ileo caecal segment (Mainz-Pouch I), ureterosigmoidostomy or bladder augmentation. Urinary tract infection and upper tract dilatation were the only complications during pregnancy which required bilateral nephrostomies in one case. All other sequelae were handled conservatively. The continence mechanisms were not compromised during pregnancy or delivery. Deliveries were vaginal in two cases and by Caesarean section in five. All seven newborn were healthy. Pregnancy is not contraindicated after any type of urinary diversion includin…

medicine.medical_specialtyPregnancybusiness.industryObstetricsmedicine.medical_treatmentUrinary systemUrinary diversionObstetrics and Gynecologymedicine.diseaseSurgeryUreterosigmoidostomyObstetrics and gynaecologyBladder augmentationMaternity and MidwiferymedicineCaesarean sectionbusinessContinent Urinary DiversionGeburtshilfe und Frauenheilkunde
researchProduct

Management of recurrent chronic anal fissure after lateral internal sphincterotomy

2021

medicine.medical_specialtyRD1-811business.industrymedicine.medical_treatmentChronic anal fissureAnal CanalAnoplastyFissurectomySurgeryTreatment OutcomeSphincterotomyChronic DiseasemedicineHumansRecurrencesSurgeryFissure in AnoLateral Internal SphincterotomyProctologybusinessLateral internal sphincterotomyFecal IncontinenceChronic anal fissureAsian Journal of Surgery
researchProduct

Safety and effectiveness of saving sphincter procedure in the treatment of chronic anal fissure in female patients.

2021

Abstract Introduction Lateral internal sphincterotomy (LIS) is still the approach of choice for the treatment of chronic anal fissure (CAF) regardless to the internal anal sphincter tone but it is burdened by high risk post-operative faecal incontinence (FI). In female patient there are some anatomical and functional differences of the sphinteric system which make them more at risk of FI and vaginal birth could cause sphinteric lesions affecting the anal continence function. The aim of our study is to evaluate the results of saving sphincter procedure as treatment for female patients affected by CAF. Methods We studied 110 female patients affected by CAF undergone fissurectomy and anoplasty…

medicine.medical_specialtyRD1-811medicine.medical_treatmentChronic anal fissureAnal CanalInternal anal sphincterFissurectomyFemale patientmedicineHumansIn patientProspective StudiesNormal rangeAnal fissurebusiness.industryGeneral MedicineAnoplastymedicine.diseaseFemale patientsSurgerymedicine.anatomical_structureTreatment OutcomeChronic DiseaseSphincterSurgeryFemaleFissure in AnoAnal fissureProctologybusinessLateral internal sphincterotomyFecal IncontinenceBMC surgery
researchProduct

Vaginal reconstruction/fistulae.

2001

Vaginal reconstruction is required in congenital absence of the vagina in the paediatric population and in patients with surgical (anterior exenteration) or traumatic loss of the vagina. Although vaginal agenesis is rare, its description and attempts at replacement vaginoplasty date back to antiquity. Different forms of vaginal reconstruction are described, including the use of split-thickness or full-thickness grafts, amnion, peritoneum or bowel. Experience with bowel segments for vaginoplasty, with few complications and high success rates, have expanded the indications for this technique, rendering it of great importance in the field of vaginal reconstruction, especially when large bowel …

medicine.medical_specialtyReconstructive SurgeonUrinary continenceVaginal reconstructionbusiness.industryUrologyFistulamedicine.medical_treatmentVaginal FistulaUrinary diversionmedicine.diseaseSurgerymedicine.anatomical_structureVaginaVaginaMedicineVaginoplastyHumansUrologic Surgical ProceduresIn patientFemalebusinessSocial AdjustmentCurrent opinion in urology
researchProduct

The European trauma course – trauma teaching goes European

2014

The World Health Organization (WHO) has identified trauma as the major health care challenge of our century, claiming more productive life years worldwide than any other disease [1]. In the European Union (EU), injury accounts for 15 % of all deaths before the age of 60 years and is the fourth most common cause of death, with more than 235,000 deaths each year from injuries, equating to 600 injury fatalities per day [2]. In children, adolescents and young adults, accident and injury rates are even higher, being the leading cause of death in these age groups. Mortality from trauma in the EU has fallen 20 % in the past 20 years, to a rate of 63.7 per 100,000 in 2010 [3]. This reduction is par…

medicine.medical_specialtyResuscitationSports medicinemedia_common.quotation_subjecteducationMEDLINETraumatologyEmergency NursingCritical Care and Intensive Care MedicineCourse (navigation)Injury preventionHealth caremedicineHumansmedia_common.cataloged_instanceOrthopedics and Sports MedicineEuropean unionmedia_commonCause of deathPatient Care TeamMedical educationTeamworkPatient care teambusiness.industryMajor traumaEmergency Respondersmedicine.diseaseEuropeAnesthesiology and Pain MedicineTraumatologyFamily medicineEmergency MedicineWounds and InjuriesEducation Medical ContinuingSurgeryCardiology and Cardiovascular MedicinebusinessResuscitation
researchProduct

Efficacy, Safety, and Confirmation of the Recommended Phase 2 Dose of Ruxolitinib Plus Panobinostat in Patients with Intermediate or High-Risk Myelof…

2014

Abstract Background: Myelofibrosis (MF) is a clonal neoplastic disease resulting in bone marrow fibrosis, splenomegaly, and debilitating constitutional symptoms. The Janus kinase (JAK) pathway is often dysregulated in MF, and agents targeting this pathway have demonstrated efficacy in this disease. Ruxolitinib (RUX), a potent JAK1/JAK2 inhibitor, demonstrated superiority in spleen volume reduction, symptom improvement, and survival compared with the control arm in the phase III COMFORT-I and COMFORT-II studies. Panobinostat (PAN), a potent pan-deacetylase inhibitor (pan-DACi), inhibits JAK signaling through disruption of the interaction of JAK2 with the protein chaperone heat shock protein …

medicine.medical_specialtyRuxolitinibThrombocytosisCombination therapybusiness.industryAnemiaImmunologyCell BiologyHematologymedicine.diseaseBiochemistryDiscontinuationchemistry.chemical_compoundchemistryInternational Prognostic Scoring SystemInternal medicinePanobinostatImmunologymedicinebusinessMyelofibrosismedicine.drugBlood
researchProduct

A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or …

2013

Abstract Background Myelofibrosis (MF) is a myeloproliferative neoplasm associated with progressive, debilitating symptoms that impact patient quality of life (QoL) and reduce survival. Ruxolitinib (RUX), a potent dual JAK1/JAK2 inhibitor, demonstrated superiority in spleen volume and symptom reduction, improved health-related QoL measures, and prolonged survival compared with traditional therapies or placebo in the phase 3 COMFORT studies. Panobinostat (PAN) is a potent oral pan-deacetylase inhibitor (DACi) that inhibits JAK pathway signaling through increased acetylation of the JAK2 protein chaperone HSP90. In phase 1/2 studies in MF, PAN has shown reduction in splenomegaly and JAK2 V617F…

medicine.medical_specialtyRuxolitinibbusiness.industryeducationImmunologyCell BiologyHematologymedicine.diseasePlaceboOff-label useBiochemistryDiscontinuationInternational Prognostic Scoring SystemInternal medicineCohortImmunologymedicineMyelofibrosisbusinessAdverse effecthealth care economics and organizationsmedicine.drugBlood
researchProduct